Skip to main content
Log in

Risk stratification of spontaneous bacterial peritonitis in cirrhosis with ascites based on classification and regression tree analysis

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Risk stratification for spontaneous bacterial peritonitis (SBP) in patients with cirrhosis and ascites helps guide care. Existing prediction models, such as end-stage liver disease (MELD) score, are accurate but controversial in clinical practice. We developed and validated a practical user-friendly bedside tool for SBP risk stratification of patients with cirrhosis and ascites. Using classification and regression tree (CART) analysis, a model was developed for prediction of SBP in cirrhosis with ascites. The CART model was derived on data collected from 676 patients admitted from January 2007 to December 2009 retrospectively, and then was prospectively tested in another independent 198 inpatients between January 2010 and December 2010. The accuracy of CART model was evaluated using the area under the receiver operating characteristic curve. The performance of the model was further validated by comparing its predictive accuracy with that of the MELD score. Furthermore, the model was used to stratify SBP among patients with MELD scores under 15. CART analysis identified four variables for prediction of SBP: creatinine, total bilirubin, prothrombin time and white blood cell count, and three risk groups: low (2.0%), intermediate (27.5–33.3%) and high (60.6–86.4%) risk. The accuracy of CART model (0.881) exceeded that of MELD (0.791). Subjects in the intermediate risk and high risk groups had 22.21-fold (95% confident interval (CI), 9.98–49.45) and 173.50-fold (95% CI, 77.68–634.33) increased risk of SBP, respectively, comparing with the low risk group. Similar results were found when this risk stratification was applied to the validation cohort. Cirrhotic patients with ascites at low, intermediate, and high risk for SBP can be easily identified using CART model, which provides clinicians with a validated, practical bedside tool for SBP risk stratification.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

A/G:

Albumin/globulin ratio

AKP:

Alkaline phosphatase

ALT:

Alanine aminotransferase

AST:

Aspartate aminotransferase

AUROC:

Area under the receiver operating characteristic curve

CART:

Classification and regression tree

CI:

Confident interval

GGT:

γ-Glutamyltransferase

HBV:

Hepatitis B virus

HE:

Hepatic encephalopathy

INR:

International normalized ratio

MELD:

Model of end-stage liver disease

OR:

Odds ratio

PT:

Prothrombin time

s:

Second

SBP:

Spontaneous bacterial peritonitis

Scr:

Serum creatinine

TB:

Total bilirubin

WBC:

White blood cell

References

  1. Altman DG, Vergouwe Y, Royston P, Moons KG (2009) Prognosis and prognostic research: validating a prognostic model. BMJ 338:b605

    Article  PubMed  Google Scholar 

  2. Andreu M, Sola R, Sitges-Serra A, Alia C, Gallen M, Vila MC, Coll S, Oliver MI (1993) Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites. Gastroenterology 104:1133–1138

    PubMed  CAS  Google Scholar 

  3. Augustin S, Muntaner L, Altamirano JT, Gonzalez A, Saperas E, Dot J, Abu-Suboh M, Armengol JR, Malagelada JR, Esteban R et al (2009) Predicting early mortality after acute variceal hemorrhage based on classification and regression tree analysis. Clin Gastroenterol Hepatol 7:1347–1354

    Article  PubMed  Google Scholar 

  4. Campillo B, Dupeyron C, Richardet JP, Mangeney N, Leluan G (1998) Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: effect of long-term administration of norfloxacin. Clin Infect Dis 26:1066–1070

    Article  PubMed  CAS  Google Scholar 

  5. European Association for the Study of the Liver (2010) EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 53:397–417

    Google Scholar 

  6. Fasolato S, Angeli P, Dallagnese L, Maresio G, Zola E, Mazza E, Salinas F, Dona S, Fagiuoli S, Sticca A et al (2007) Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features. Hepatology 45:223–229

    Article  PubMed  Google Scholar 

  7. Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, Rodes J (2002) Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 35:140–148

    Article  PubMed  Google Scholar 

  8. Fernandez J, Navasa M, Planas R, Montoliu S, Monfort D, Soriano G, Vila C, Pardo A, Quintero E, Vargas V et al (2007) Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 133:818–824

    Article  PubMed  CAS  Google Scholar 

  9. Gayatri AA, Suryadharma IG, Purwadi N, Wibawa ID (2007) The relationship between a model of end stage liver disease score (MELD score) and the occurrence of spontaneous bacterial peritonitis in liver cirrhotic patients. Acta Med Indones 39:75–78

    PubMed  Google Scholar 

  10. Ghassemi S, Garcia-Tsao G (2007) Prevention and treatment of infections in patients with cirrhosis. Best Pract Res Clin Gastroenterol 21:77–93

    Article  PubMed  Google Scholar 

  11. Guarner C, Sola R, Soriano G, Andreu M, Novella MT, Vila MC, Sabat M, Coll S, Ortiz J, Gomez C, Balanzo J (1999) Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels. Gastroenterology 117:414–419

    Article  PubMed  CAS  Google Scholar 

  12. Khan J, Pikkarainen P, Karvonen AL, Makela T, Peraaho M, Pehkonen E, Collin P (2009) Ascites: aetiology, mortality and the prevalence of spontaneous bacterial peritonitis. Scand J Gastroenterol 44:970–974

    Article  PubMed  Google Scholar 

  13. Kurosaki M, Sakamoto N, Iwasaki M, Sakamoto M, Suzuki Y, Hiramatsu N, Sugauchi F, Yatsuhashi H, Izumi N (2011) Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis. J Gastroenterol 46:401–409

    Google Scholar 

  14. Lee JM, Han KH, Ahn SH (2009) Ascites and spontaneous bacterial peritonitis: an Asian perspective. J Gastroenterol Hepatol 24:1494–1503

    Article  PubMed  Google Scholar 

  15. Llach J, Rimola A, Navasa M, Gines P, Salmeron JM, Gines A, Arroyo V, Rodes J (1992) Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration. Hepatology 16:724–727

    Article  PubMed  CAS  Google Scholar 

  16. Loomba R, Wesley R, Bain A, Csako G, Pucino F (2009) Role of fluoroquinolones in the primary prophylaxis of spontaneous bacterial peritonitis: meta-analysis. Clin Gastroenterol Hepatol 7:487–493

    Article  PubMed  Google Scholar 

  17. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31:864–871

    Article  PubMed  CAS  Google Scholar 

  18. Obstein KL, Campbell MS, Reddy KR, Yang YX (2007) Association between model for end-stage liver disease and spontaneous bacterial peritonitis. Am J Gastroenterol 102:2732–2736

    Article  PubMed  Google Scholar 

  19. Runyon BA (2009) Management of adult patients with ascites due to cirrhosis: an update. Hepatology 49:2087–2107

    Article  PubMed  Google Scholar 

  20. Sola E, Gines P (2010) Renal and circulatory dysfunction in cirrhosis: current management and future perspectives. J Hepatol 53:1135–1145

    Article  PubMed  Google Scholar 

  21. Wu BU, Johannes RS, Sun X, Tabak Y, Conwell DL, Banks PA (2008) The early prediction of mortality in acute pancreatitis: a large population-based study. Gut 57:1698–1703

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by grants from the Scientific Research Foundation of Wenzhou, Zhejiang Province, China (H20090014, Y20090269), Health Bureau of Zhejiang Province (2010KYB070), Research Foundation of Education Bureau of Zhejiang Province (Y201009942) Natural Science Foundation of Shandong Province (ZR2010HQ040), Independent Innovation Foundation of Shandong University (IIFSDU, 2010TS013) and Project of New Century 551 Talent Nurturing in Wenzhou.

Conflict of interest

No conflicts of interest exist.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ming-Hua Zheng.

Additional information

K.-Q. Shi and Y.-C. Fan are co-first author.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Table 1

Subgroup analysis of the patients with the MELD score (DOC 28 kb)

Supplementary Fig. 1

Predictors of SBP and risk stratification for the validation cohort. Terminal subgroups of patients discriminated by the analysis were numbered from one to six. PT prothrombin time, SBP spontaneous bacterial peritonitis, Scr serum creatinine, TB total bilirubine, WBC white blood cell (TIFF 976 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shi, KQ., Fan, YC., Ying, L. et al. Risk stratification of spontaneous bacterial peritonitis in cirrhosis with ascites based on classification and regression tree analysis. Mol Biol Rep 39, 6161–6169 (2012). https://doi.org/10.1007/s11033-011-1432-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-011-1432-8

Keywords

Navigation